REQUEST A DEMO
Total
USD $0.00
Search more companies

Cliniplus I.P.S. S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Cliniplus I.P.S. S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cliniplus I.P.S. S.A.S. is an enterprise based in Colombia. Its main office is in Barranquilla. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on July 17, 2013. Cliniplus I.P.S. S.A.S. currently employs 7 (2023) people. The company’s latest financial report indicates a net sales revenue increase of 23.01% in 2023. Its’ total assets recorded a growth of 16.65%. In 2023, Cliniplus I.P.S. S.A.S.’s net profit margin increased by 5.74%.

Headquarters
Cr 45 # 70 - 162 Locales 11A - 12A
Barranquilla; Atlantico;

Contact Details: Purchase the Cliniplus I.P.S. S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Cliniplus I.P.S. S.A.S. report to view the information.
Outstanding Shares:
Purchase the Cliniplus I.P.S. S.A.S. report to view the information.
Incorporation Date:
July 17, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Cliniplus I.P.S. S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
23.01%
Total operating revenue
23.01%
Operating profit (EBIT)
292.35%
Net Profit (Loss) for the Period
145.58%
Total assets
16.65%
Total equity
16.3%
Operating Profit Margin (ROS)
12.61%
Net Profit Margin
5.74%
Return on Equity (ROE)
7.5%
Quick Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?